BioSpace News Archive

What’s New: In a joint paper published in Nature Machine Intelligence, researchers from Intel Labs and Cornell University demonstrated the ability of Intel’s neuromorphic research chip, Loihi, to learn and recognize hazardous chemicals in the presence of significant noise and occlusion.

H4D, a leading global telemedicine company, is joining the international effort to fight the global coronavirus pandemic. H4D is providing hospitals with a fast, efficient and reliable solution to improve patient flow management in the emergency department

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on trends driving the pharma industry.

EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, today announced that the prestigious peer-reviewed journal Cancer Cell has published a scientific paper, authored by EnGeneIC’s research team, entitled “Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocell.”

In addition to our industry-leading safety and quality standards across all three of our care divisions, AIS Healthcare is implementing additional measures in response to COVID-19.

Hackensack University Medical Center, a national leader in orthopedic care and robotic surgery, recently completed the first total knee replacement using the TSolution One® Total Knee Application.

The National Kidney Registry (NKR) and Viracor Eurofins announced a partnership today to deliver testing for Coronavirus SARS-CoV-2 (the virus that causes COVID-19 disease) to NKR’s vast network of Member Centers

The UNC Medical Center McLendon Clinical Laboratories in Chapel Hill have developed a diagnostic test for coronavirus disease 2019 based on a World Health Organization assay. The UNC test is now in use at the medical center in Chapel Hill, NC.

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the first participant has been dosed in the Phase 1 study of the Company’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2).

The Delta Companies (TDC), a leading healthcare staffing firm for providers nationwide, has announced the acquisition of Dallas-based Foreman Therapy Services (FTS), a therapy-focused staffing company specializing in home health